Fitch revises Hackensack University Medical Center’s outlook to positive

Fitch Ratings has revised Hackensack (N.J.) University Medical Center’s outlook to positive from stable and upgraded the rating to “A” from “A-” on the following bonds:

Advertisement

  • $221.2 million of series 2008 bonds
  • $68.3 million of series 2010A bonds
  • $100.3 million of series 2010B bonds
  • $52.8 million of series 1997 bonds

The outlook revision and rating upgrade are based on several factors, including Hackensack’s steady profitability, solid market position and the anticipated benefits from the merger between Hackensack’s parent, Hackensack (N.J.) University Health Network, and Neptune, N.J.-based Meridian Health.

More articles on healthcare finance:
S&P assigns ‘AA’ rating to Mayo Clinic’s bonds
13 recent hospital outlook and credit rating actions
33 hospitals, health systems seeking RCM talent

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.